Detalhe da pesquisa
1.
Contrasting genomic profiles from metastatic sites, primary tumors, and liquid biopsies of advanced prostate cancer.
Cancer
; 127(24): 4557-4564, 2021 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34379803
2.
RAS Amplification as a Negative Predictor of Benefit from Anti-EGFR-Containing Therapy Regimens in Metastatic Colorectal Cancer.
Oncologist
; 26(6): 469-475, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33465286
3.
Recurrent urothelial carcinoma-like FGFR3 genomic alterations in malignant Brenner tumors of the ovary.
Mod Pathol
; 34(5): 983-993, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33077920
4.
Real-world association of HER2/ERBB2 concordance with trastuzumab clinical benefit in advanced esophagogastric cancer.
Future Oncol
; 17(31): 4101-4114, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34463133
5.
Long-term follow-up confirms the favourable prognostic impact of high numbers of tumour infiltrating CD3 T-cells in follicular lymphoma patients treated by rituximab-maintenance regimen.
Br J Haematol
; 202(3): 686-689, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37218065
6.
Treatment dependence of prognostic gene expression signatures in de novo follicular lymphoma.
Blood
; 137(19): 2704-2707, 2021 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33512481
7.
Recipient HLA-C Haplotypes and microRNA 148a/b Binding Sites Have No Impact on Allogeneic Hematopoietic Cell Transplantation Outcomes.
Biol Blood Marrow Transplant
; 23(1): 153-160, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27746218
8.
KIR and HLA genotypes predictive of low-affinity interactions are associated with lower relapse in autologous hematopoietic cell transplantation for acute myeloid leukemia.
J Immunol
; 194(9): 4222-30, 2015 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25810393
9.
HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.
N Engl J Med
; 367(9): 805-16, 2012 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-22931314
10.
Frequent inactivating mutations of the PBAF complex gene PBRM1 in meningioma with papillary features.
Acta Neuropathol
; 140(1): 89-93, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32405805
11.
Chromosome 8q arm overexpression is associated with worse prostate cancer prognosis.
Urol Oncol
; 41(2): 106.e17-106.e23, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36400666
12.
Donor activating KIR2DS1 in leukemia.
N Engl J Med
; 371(21): 2042, 2014 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25409391
13.
Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation.
Blood
; 115(15): 3162-5, 2010 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20124216
14.
ERBB2 Copy Number as a Quantitative Biomarker for Real-World Outcomes to Anti-Human Epidermal Growth Factor Receptor 2 Therapy in Advanced Gastroesophageal Adenocarcinoma.
JCO Precis Oncol
; 6: e2100330, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35050711
15.
APOBEC Mutational Signatures in Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancers Are Associated With Poor Outcomes on CDK4/6 Inhibitors and Endocrine Therapy.
JCO Precis Oncol
; 6: e2200149, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36315915
16.
Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancer.
Nat Commun
; 13(1): 7495, 2022 12 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36470901
17.
Predictive Genomic Biomarkers of Hormonal Therapy Versus Chemotherapy Benefit in Metastatic Castration-resistant Prostate Cancer.
Eur Urol
; 81(1): 37-47, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34716049
18.
The Genomics of Colorectal Cancer in Populations with African and European Ancestry.
Cancer Discov
; 12(5): 1282-1293, 2022 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35176763
19.
Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma.
Nat Commun
; 13(1): 3406, 2022 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35705558
20.
Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation.
Blood
; 113(16): 3875-84, 2009 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-19179302